Stock 301301 YILI CHUANNING BIOTECHNOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Yili Chuanning Biotechnology Co.,Ltd.

Equities

301301

CNE100005WX0

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
15.65 CNY +0.97% Intraday chart for Yili Chuanning Biotechnology Co.,Ltd. -7.45% +86.31%
Apr. 21 Yili Chuanning Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 10 Yili Chuanning Biotechnology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Yili Chuanning Biotechnology Co Ltd is a China-based company mainly engaged in the research, development and industrialization of biological fermentation technology. The Company's products mainly include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, crude ursodeoxycholic acid, coenzyme Q10 mycelium and others. The Company's products are mainly exported to countries such as India.

Number of employees: 2,881

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical Intermediates
92.2 %
3,531 92.4 % 4,447 92.2 % +25.94%
Other
6.4 %
247 6.5 % 309 6.4 % +25.07%
Other Products
1.4 %
43 1.1 % 68 1.4 % +57.75%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
3,821 100.0 % 4,823 100.0 % +26.24%

Managers

Managers TitleAgeSince
Xu Heng Deng CEO
 Chief Executive Officer 37 20-06-17
Fan Yang CHM
 Chairman 44 10-12-31
Yi Xing Li DFI
 Director of Finance/CFO 40 13-12-31
Xiang Gu IRC
 Investor Relations Contact 32 20-03-31

Members of the board

Members of the board TitleAgeSince
Ge Xin Liu CHM
 Chairman 73 20-06-17
Si Chuan Liu BRD
 Director/Board Member 40 20-06-17
Xu Heng Deng CEO
 Chief Executive Officer 37 20-06-17
Ya Li Cao BRD
 Director/Board Member 49 21-06-01
Xian Li Gao BRD
 Director/Board Member 45 21-06-16
Hong Duan BRD
 Director/Board Member 60 20-10-26
Yi Xing Li DFI
 Director of Finance/CFO 40 13-12-31
Xian Zhong Zhou BRD
 Director/Board Member 40 15-09-30
Fan Yang CHM
 Chairman 44 10-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,227,160,000 232,630,677 ( 10.45 %) 0 10.45 %

Shareholders

NameEquities%Valuation
Shanghai Orient Securities Xiyi Equity Investment Fund Pp LP
16.32 %
100,000,000 16.32 % 182 M ¥
Haining Dongjun Weizhong Investment LP
15.77 %
96,629,213 15.77 % 176 M ¥
Hongyuan Huifu Investment Ltd.
9.789 %
60,000,000 9.789 % 109 M ¥
Shouguang Yihang Investment LP
8.286 %
50,786,516 8.286 % 92 M ¥
Shouguang Huining Chiyuan Investment LP
3.710 %
22,741,573 3.710 % 41 M ¥
Shouguang Zhongju Ningcheng Investment LP
2.713 %
16,629,213 2.713 % 30 M ¥
Shouguang Yihong Jutou Investment LP
2.713 %
16,629,213 2.713 % 30 M ¥
Shouguang Yisirong Investment LP
2.522 %
15,460,674 2.522 % 28 M ¥
China Universal Asset Management Co., Ltd.
0.7321 %
4,487,384 0.7321 % 8 M ¥
Wen Bo Huang
0.3441 %
2,109,164 0.3441 % 4 M ¥
NameEquities%Valuation
SICHUAN KELUN PHARMACEUTICAL CO., LTD.
97.52 %
1,569,887,643 97.52 % 2 857 M ¥
Chengdu Kelun Ninghui Enterprise Management Pp LP
2.485 %
40,000,000 2.485 % 73 M ¥

Company contact information

Yili Chuannig Biotechnology Co., Ltd.

516, Almatyya Village, Yining Park Horgos Economic Development Zone

835000, Korgas

+86 99 9807 7777

http://www.klcnsw.com
address Yili Chuanning Biotechnology Co.,Ltd.(301301)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Yili Chuanning Biotechnology Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
15.65 CNY
Average target price
10.6 CNY
Spread / Average Target
-32.27%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
YILI CHUANNING BIOTECHNOLOGY CO.,LTD. Stock Yili Chuanning Biotechnology Co.,Ltd.
+86.31% 4.83B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 693B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 584B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 372B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 211B
NOVARTIS AG Stock Novartis AG
+10.02% 210B
AMGEN INC. Stock Amgen Inc.
+8.49% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 301301 Stock
  4. Company Yili Chuanning Biotechnology Co.,Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW